Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone

Ease of Use and Tolerability of Norditropin NordiFlex® in Growth Hormone naïve Children: Impact on Daily Life

This study is conducted in Europe. The purpose of this study is to assess the impact on daily life for children new to using a growth hormone injection device.

Inclusion Criteria:

• Growth hormone (GH) treatment naïve subjects for whom it has been decided to initiate GH treatment prior to enrollment into the study
• Subjects who receive Norditropin NordiFlex® according to the SPC

Exclusion Criteria:

• Known or suspected allergy to study product(s) or related products
• Child and/or parent unable to give consent or fill out the questionnaires
• The receipt of any investigational medicinal product within 3 months prior to this study
• Suffer from a life-threatening disease